Study on Womens Views About Using Vaginal Fluid DNA Testing for Early Detection of Endometrial Cancer

What this Trial Is About

This research aims to understand how women feel about using DNA from vaginal fluid to detect endometrial cancer early. The study focuses on women aged 45 and older who identify as Black and have an intact uterus, particularly those who have experienced abnormal or post-menopausal bleeding. It is an observational study sponsored by Mayo Clinic to explore patient acceptability of this testing method. Participants take part in a single 45-minute virtual interview where they discuss their views and experiences related to vaginal fluid collection for DNA analysis. This study does not involve any experimental treatments or interventions but collects opinions to guide future testing approaches. During the study, participants are asked questions about their feelings toward this testing method. The primary outcome is to measure how acceptable the vaginal fluid collection is for early detection of endometrial cancer. The study is conducted virtually, minimizing participant burden, and finishes with this one-time interview session.

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer